Accreditation
+
Available Dates
May 17-18 | New York City |View upcoming dates
Accreditation
Accreditation
Intended Audience
This educational activity is designed to meet the educational needs of those who are involved and/or interested in the treatment of patients with GI cancers, community oncologists, physicians, physician assistants, physicians-in-training, oncology nurses, and pharmacists.
Learning Objectives
Upon successful completion of these educational activities, participants should be able to:
- Analyze the mechanism of action (MOA) and safety-efficacy profiles of currently approved and emerging oncological agents, including immunotherapies and molecularly targeted agents for the management of GI malignancies
- Integrate clinical trial data and evidence-based therapies for improving clinical outcomes in patients with GI malignancies
- Evaluate the best practices and standards of care, based on a multidisciplinary approach for the management of GI cancers
- Implement the rational use of immunotherapies in patients with GI malignancies on a case-by-case basis
- Define patient populations most suitable for enrolling in GI clinical trials for progressive advanced-stage GI malignancies
- Implement optimal management strategies for both metastatic and non-metastatic GI malignancies based on personalized factors such as comorbidities, cost, disease stage, and prior therapeutic regimens
- Evaluate the role of blood-based molecular profiling approaches for early diagnosis of metastatic disease and treatment monitoring
- Explore the more clearly defined role of neoadjuvant and adjuvant strategies in GI malignancies
- Explore the emerging role of blood-based molecular markers of minimal residual disease, dynamic evaluation of patients in therapy to identify emergence of therapy resistance, and how these biomarkers will define treatment of adjuvant therapy patients and advanced disease
- Define the expanding role of interventional radiology in therapeutics
Accreditation Statement
In support of improving patient care, HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Note: This statement is not an indication of approved credits. Please see below for full accreditation details, including credit types and totals, for this activity.
Please visit each page for specific credit hours designated per activity.
Intended Audience
This educational activity is designed to meet the educational needs of those who are involved and/or interested in the treatment of patients with GI cancers, community oncologists, physicians, physician assistants, physicians-in-training, oncology nurses, and pharmacists.
Learning Objectives
Upon successful completion of these educational activities, participants should be able to:
- Analyze the mechanism of action (MOA) and safety-efficacy profiles of currently approved and emerging oncological agents, including immunotherapies and molecularly targeted agents for the management of GI malignancies
- Integrate clinical trial data and evidence-based therapies for improving clinical outcomes in patients with GI malignancies
- Evaluate the best practices and standards of care, based on a multidisciplinary approach for the management of GI cancers
- Implement the rational use of immunotherapies in patients with GI malignancies on a case-by-case basis
- Define patient populations most suitable for enrolling in GI clinical trials for progressive advanced-stage GI malignancies
- Implement optimal management strategies for both metastatic and non-metastatic GI malignancies based on personalized factors such as comorbidities, cost, disease stage, and prior therapeutic regimens
- Evaluate the role of blood-based molecular profiling approaches for early diagnosis of metastatic disease and treatment monitoring
- Explore the more clearly defined role of neoadjuvant and adjuvant strategies in GI malignancies
- Explore the emerging role of blood-based molecular markers of minimal residual disease, dynamic evaluation of patients in therapy to identify emergence of therapy resistance, and how these biomarkers will define treatment of adjuvant therapy patients and advanced disease
- Define the expanding role of interventional radiology in therapeutics
Accreditation Statement
In support of improving patient care, HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Note: This statement is not an indication of approved credits. Please see below for full accreditation details, including credit types and totals, for this activity.
Please visit each page for specific credit hours designated per activity.
ADA STATEMENT
HMP Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity needs accommodation(s), please submit a request to contact the support team.
COMMERCIAL SUPPORT
Applications for commercial support from healthcare-related industries are pending. Commercial support will be acknowledged as it is received.
NON-ACCREDITED INNOVATION THEATERS
These are promotional programs at which no CE credits are offered. All attendees, please be advised that information—e.g., your name and the value of any meal you receive during these promotional programs—may be publicly disclosed pursuant to applicable federal and/or state laws. If you are licensed in a state or are an employee of an organization that limits or prohibits meals from pharmaceutical companies, please identify yourself so that everyone is able to comply with such requirements.
CONTACT US
For immediate assistance, please explore our HMP Education Help Center or chat with our Virtual CE Assistant who can answer most common questions related to claiming credits and the HMP Education website. If you have a question or grievance that cannot be answered by our Virtual CE assistant and Help Center, please submit a request to contact the support team. Our accreditation and compliance team will respond to your inquiry within 1 business day.
FREQUENTLY ASKED QUESTIONS
DISCLAIMERS
The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a provider-patient relationship. Medical advice of any nature should be sought from an individual’s own provider.
The opinions expressed in this educational activity are those of the faculty and are not attributable to HMP Global or any of its subsidiaries or affiliates. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.
PRIVACY POLICY
HMP Education protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. HMP Education and our joint providers will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. HMP Education maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
Copyright © 2024 by HMP Education. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from HMP Education.
ADA STATEMENT
HMP Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity needs accommodation(s), please submit a request to contact the support team.
COMMERCIAL SUPPORT
Applications for commercial support from healthcare-related industries are pending. Commercial support will be acknowledged as it is received.
NON-ACCREDITED INNOVATION THEATERS
These are promotional programs at which no CE credits are offered. All attendees, please be advised that information—e.g., your name and the value of any meal you receive during these promotional programs—may be publicly disclosed pursuant to applicable federal and/or state laws. If you are licensed in a state or are an employee of an organization that limits or prohibits meals from pharmaceutical companies, please identify yourself so that everyone is able to comply with such requirements.
CONTACT US
For immediate assistance, please explore our HMP Education Help Center or chat with our Virtual CE Assistant who can answer most common questions related to claiming credits and the HMP Education website. If you have a question or grievance that cannot be answered by our Virtual CE assistant and Help Center, please submit a request to contact the support team. Our accreditation and compliance team will respond to your inquiry within 1 business day.
FREQUENTLY ASKED QUESTIONS
DISCLAIMERS
The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a provider-patient relationship. Medical advice of any nature should be sought from an individual’s own provider.
The opinions expressed in this educational activity are those of the faculty and are not attributable to HMP Global or any of its subsidiaries or affiliates. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.
PRIVACY POLICY
HMP Education protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. HMP Education and our joint providers will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. HMP Education maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
Copyright © 2024 by HMP Education. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from HMP Education.